CD44s and CD44v6 expression in head and neck epithelia

PLoS ONE

Volumn 3, Issue 10, 2008, Pages

  Mack, Brigitte ^a   Gires, Olivier ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V6 ANTIGEN; HERMES ANTIGEN; CD44S ANTIGEN; ISOPROTEIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CARCINOMA IN SITU; CELL LINE; CELL SURFACE; CONTROLLED STUDY; EPITHELIUM; FLOW CYTOMETRY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; LYMPHOCYTE; LYMPHOID CELL; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; CHEMISTRY; HEAD; HEAD AND NECK TUMOR; NECK; PATHOLOGY; TISSUE DISTRIBUTION;

ANTIGENS, CD44; CARCINOMA, SQUAMOUS CELL; EPITHELIUM; HEAD; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; NECK; PROTEIN ISOFORMS; TISSUE DISTRIBUTION;

EID: 54449085703     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003360     Document Type: Article

References (30)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
2. Naor D, Wallach-Dayan SB, Zahalka MA, Sionov RV (2008) Involvement of CD44, a molecule with a thousand faces, in cancer dissemination. Semin Cancer Biol 18: 260-267.
3. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4: 33-45.
4. Trowbridge IS, Lesley J, Schulte R, Hyman R, Trotter J (1982) Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 15: 299-312.
5. Kuhn S, Koch M, Nubel T, Ladwein M, Antolovic D, et al. (2007) A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res 5: 553-567.
6. Gunthert U, Hofmann M, Rudy W, Reber S, Zoller M, et al. (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24.
7. Okamoto I, Kawano Y, Matsumoto M, Suga M, Kaibuchi K, et al. (1999) Regulated CD44 cleavage under the control of protein kinase C, calcium influx, and the Rho family of small G proteins. J Biol Chem 274: 25525-25534.
8. Lammich S, Okochi M, Takeda M, Kaether C, Capell A, et al. (2002) Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 277: 44754-44759.
9. Nagano O, Murakami D, Hartmann D, De Strooper B, Saftig P, et al. (2004) Cell-matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca(2+) influx and PKC activation. J Cell Biol 165: 893-902.
10. Nagano O, Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95: 930-935.
11. Okamoto I, Kawano Y, Murakami D, Sasayma T, Araki N, et al. (2001) Proteolytic release of GD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 155: 755-762.
12. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100: 3983-3988.
13. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, et al. (2007) Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A 104: 10158-10163.
14. Pries R, Witrkopf N, Trenkle T, Nitsch SM, Wollenberg B (2008) Potential stem cell marker CD44 is constitutively expressed in permanent cell lines of head and neck cancer. In Vivo 22: 89-92.
15. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, et al. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104: 973-978.
16. Prince ME, Ailles LE (2008) Cancer stem cells in head and neck squamous cell cancer. J Clin Oncol 26: 2871-2875.
17. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, et al. (2008) CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. J Clin Invest 118: 2111-2120.
18. Soukka T, Salmi M, Joensuu H, Hakkinen L, Sointu P, et al. (1997) Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cell. Cancer Res 57: 2281-2289.
19. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, et al. (1996) Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 179: 66-73.
20. van Hal NL, van Dongen GA, Stigter-van Walsum M, Snow GB, Brakenhoff RH (1999) Characterization of CD44v6 isoforms in head-and-neck squamous-cell carcinoma. Int J Cancer 82: 837-845.
21. Van Hal NL, Van Dongen GA, Ten Brink CB, Heider KH, Rech-Weichselbraun I, et al. (1999) Evaluation of soluble CD44v6 as a potential serum marker for head and neck squamous cell carcinoma. Clin Cancer Res 5: 3534-3541.
22. Reichart PA, Philipsen HP (2005) Oral erythroplakia - a review. Oral Oncol 41: 551-561.
23. Wiesner M, Zentz C, Mayr C, Wimmer R, Hammerschmidt W, et al. (2008) Conditional immortalization of human B cells by CD40 ligation. PLoS ONE 3: e1464.
24. Cho RW, Clarke MF (2008) Recent advances in cancer stem cells. Curr Opin Genet Dev 18: 48-53.
25. Baeuerle PA, Gires O (2007) EpCAM (CD326) finding its role in cancer. Br J Cancer 96: 417-423.
26. Gires O (2008) TACSTD1 (tumor-associated calcium signal transducer 1). Atlas Genet Cytogenet Oncol Haematol: http://AtlasGeneticsOncology.org/ Genes/TACSTD1ID42459ch42452p42421.html.
27. Kawano T, Nakamura Y, Yanoma S, Kubota A, Furukawa M, et al. (2004) Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer. Auris Nasus Larynx 31: 35-41.
28. Marhaba R, Bourouba M, Zoller M (2005) CD44v6 promotes proliferation by persisting activation of MAP kinases. Cell Signal 17: 961-973.
29. Cheng C, Yaffe ME, Sharp PA (2006) A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20: 1715-1720.
30. Staibano S, Merolla F, Testa D, Iovine R, Mascolo M, et al. (2007) OPN/ CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br J Cancer 97: 1545-1551.